KEY PRODUCTS
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
01 1Swati Spentose
01 1MELOXICAM
01 1India
01 1Active
01 1Complete
SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
GDUFA
DMF Review : Complete
Rev. Date : 2013-10-05
Pay. Date : 2013-09-25
DMF Number : 18837
Submission : 2005-09-30
Status : Active
Type : II
20
Swati Spentose Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
They are recognized for SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.
One of their notable products is MELOXICAM, with a corresponding US DMF Number 18837.
Remarkably, this DMF maintains an Active status since its submission on September 30, 2005, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 05, 2013, and payment made on September 25, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
